| Primary |
| Chronic Infantile Neurological Cutaneous And Articular Syndrome |
12.5% |
| Juvenile Arthritis |
12.5% |
| Juvenile Idiopathic Arthritis |
12.5% |
| Still's Disease Adult Onset |
12.5% |
| Autoinflammatory Disease |
8.3% |
| Gout |
6.3% |
| Rheumatoid Arthritis |
6.3% |
| Inflammation |
4.2% |
| Still's Disease Adult Onset |
2.1% |
| Acute Myocardial Infarction |
2.1% |
| Behcet's Syndrome |
2.1% |
| Cryopyrin Associated Periodic Syndrome |
2.1% |
| Deficiency Of The Interleukin-1 Receptor Antagonist |
2.1% |
| Gouty Arthritis |
2.1% |
| Histiocytosis Haematophagic |
2.1% |
| Muckle-wells Syndrome |
2.1% |
| Myalgia |
2.1% |
| Neonatal-onset Multisystemic Inflammatory Disease |
2.1% |
| Psoriatic Arthropathy |
2.1% |
| Schnitzler's Syndrome |
2.1% |
|
| Vomiting |
13.3% |
| Histiocytosis Haematophagic |
6.7% |
| Joint Warmth |
6.7% |
| Rash |
6.7% |
| Renal Impairment |
6.7% |
| Respiratory Disorder |
6.7% |
| Therapy Cessation |
6.7% |
| Treatment Noncompliance |
6.7% |
| Anal Squamous Cell Carcinoma |
3.3% |
| Aspartate Aminotransferase Increased |
3.3% |
| Bilirubin Conjugated Increased |
3.3% |
| Cardiac Failure |
3.3% |
| Cellulitis |
3.3% |
| Death |
3.3% |
| Dermatitis |
3.3% |
| Foetal Exposure During Pregnancy |
3.3% |
| Furuncle |
3.3% |
| Haemorrhage Intracranial |
3.3% |
| Hepatocellular Injury |
3.3% |
| Injection Site Erythema |
3.3% |
|
| Secondary |
| Rheumatoid Arthritis |
22.7% |
| Product Used For Unknown Indication |
19.3% |
| Polyarthritis |
16.3% |
| Juvenile Arthritis |
15.5% |
| Drug Use For Unknown Indication |
5.2% |
| Autoinflammatory Disease |
3.4% |
| Polychondritis |
3.0% |
| Prophylaxis |
2.6% |
| Schnitzler's Syndrome |
2.6% |
| Chronic Infantile Neurological Cutaneous And Articular Syndrome |
1.3% |
| Febrile Convulsion |
1.3% |
| Antiphospholipid Syndrome |
0.9% |
| Histiocytosis Haematophagic |
0.9% |
| Hyperlipidaemia |
0.9% |
| Mevalonate Kinase Deficiency |
0.9% |
| Myocardial Ischaemia |
0.9% |
| Osteoporosis |
0.9% |
| Vitamin D Deficiency |
0.9% |
| Blood Pressure Abnormal |
0.4% |
| Hyper Igd Syndrome |
0.4% |
|
| Weight Decreased |
17.6% |
| Hypertension |
8.8% |
| Metastatic Bronchial Carcinoma |
8.8% |
| Oropharyngeal Pain |
8.8% |
| Hodgkin's Disease |
5.9% |
| Renal Disorder |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Anaphylactic Reaction |
2.9% |
| Cardiac Arrest |
2.9% |
| Cardiac Failure Congestive |
2.9% |
| Diabetes Mellitus |
2.9% |
| Diverticular Perforation |
2.9% |
| Drug Ineffective |
2.9% |
| Epidural Lipomatosis |
2.9% |
| Erythema |
2.9% |
| Hepatic Lesion |
2.9% |
| Hepatitis |
2.9% |
| Histiocytosis Haematophagic |
2.9% |
| Joint Tuberculosis |
2.9% |
| Liver Abscess |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.0% |
| Product Used For Unknown Indication |
11.2% |
| Juvenile Arthritis |
10.9% |
| Rheumatoid Arthritis |
9.0% |
| Gout |
7.5% |
| Polyarthritis |
6.4% |
| Cryopyrin Associated Periodic Syndrome |
4.1% |
| Eczema |
3.4% |
| Juvenile Idiopathic Arthritis |
3.4% |
| Arthritis |
3.0% |
| Blood Pressure Abnormal |
3.0% |
| Behcet's Syndrome |
2.2% |
| Synovitis |
2.2% |
| Familial Mediterranean Fever |
1.9% |
| Allergy Prophylaxis |
1.5% |
| Blood Pressure |
1.5% |
| Polychondritis |
1.5% |
| Conjunctivitis Allergic |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Renal Failure Chronic |
1.1% |
|
| Renal Failure Acute |
11.8% |
| Respiratory Failure |
11.8% |
| Papilloedema |
8.8% |
| Epidural Lipomatosis |
5.9% |
| Hepatotoxicity |
5.9% |
| Pyrexia |
5.9% |
| Thrombophlebitis |
5.9% |
| Viral Infection |
5.9% |
| Weight Increased |
5.9% |
| Abdominal Pain |
2.9% |
| Abdominal Pain Upper |
2.9% |
| Abnormal Behaviour |
2.9% |
| Appendicitis |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Cytomegalovirus Infection |
2.9% |
| Drug Ineffective |
2.9% |
| Erythema |
2.9% |
| Escherichia Urinary Tract Infection |
2.9% |
| Eye Pain |
2.9% |
| Hepatocellular Injury |
2.9% |
|
